Chemoinformaics analysis of (-)-DEHYDROAROMADENDRENE
| Molecular Weight | 202.341 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 14 |
| Exact Molecular Weight | 202.172 | nRing | 3 |
| Solubility: LogS | -5.331 | nHRing | 0 |
| Solubility: LogP | 4.496 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 39.7194 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.556 |
| Synth | 4.768 |
| Natural Product Likeliness | 2.98 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -4.685 |
| MDCK | 0.000041 |
| BBB | 0.815 |
| PPB | 0.944223 |
| VDSS | 3.002 |
| FU | 0.0366329 |
| CYP1A2-inh | 0.462 |
| CYP1A2-sub | 0.423 |
| CYP2c19-inh | 0.197 |
| CYP2c19-sub | 0.917 |
| CYP2c9-inh | 0.452 |
| CYP2c9-sub | 0.23 |
| CYP2d6-inh | 0.009 |
| CYP2d6-sub | 0.577 |
| CYP3a4-inh | 0.311 |
| CYP3a4-sub | 0.521 |
| CL | 16.775 |
| T12 | 0.059 |
| hERG | 0.035 |
| Ames | 0.008 |
| ROA | 0.728 |
| SkinSen | 0.34 |
| Carcinogencity | 0.161 |
| EI | 0.03 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.863764 |